Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination.

Front Immunol · 2022 · PMC9471319 · PMID 36119053

Europe PMC DOI

hedged sentence

0.0677

closest p · 1.4× alpha

0.0677

boldest claim

The sentences

borderline significancep=0.0677so close (0.05 < p ≤ 0.1)

Using a cell-based assay we depicted a reduced neutralization capacity in the Ofa group compared to HC against wild type (WT, p=0.0220), Delta with borderline significance (p=0.0677) and Omicron (p=0.0208) variants ( Figures 3A–C ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.